John H. Sampson

Also affiliated with University of Colorado Boulder, University of Colorado System, Duke Medical Center, Stanford Medicine, Duke University Hospital, Pediatric Brain Tumor Foundation, Neurological Surgery, Duke Cancer Institute, University of Colorado Anschutz Medical Campus, Stanford University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?”.

PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1135

N/A

0DataRank · unranked

126 citations

David A. Reardon, Michael Weller, John H. Sampson, Mustafa Khasraw

Oncolytic virus-derived type I interferon restricts CAR T cell therapy

Nature Communications(2020)10.1038/s41467-020-17011-z

N/A

0DataRank · unranked

120 citations

Amanda L. Huff, Phonphimon Wongthida, Jill Thompson, Tim Kottke, Jason M. Tonne +15 more

Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1082

N/A

0DataRank · unranked

101 citations

Duane A. Mitchell, Patrick Healy, James E. Herndon, John H. Sampson, Kristen A. Batich

Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook

Expert Review of Clinical Pharmacology(2020)10.1080/17512433.2020.1817737

N/A

0DataRank · unranked

20 citations

Cosette D. Champion, Kristen E. Rhodin, Karolina Woroniecka, Hanna Kemeny, Alexa N. Bramall +4 more

First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000213

N/A

0DataRank · unranked

27 citations

David J. Snyder, Ivan Spasojević, Patrick C. Gedeon, Luis Sánchez-Pérez, John H. Sampson +1 more

GLP toxicology study of a fully-human T cell redirecting CD3:EGFRvIII binding immunotherapeutic bispecific antibody

PLoS ONE(2020)10.1371/journal.pone.0236374

N/A

0DataRank · unranked

7 citations

Michael A. Streicker, Teilo Schaller, Gary E. Archer, Micheal P. Jokinen, John H. Sampson +1 more

Phase I trial of D2C7 immunotoxin (D2C7-IT) administered intratumorally via convection-enhanced delivery (CED) for recurrent malignant glioma (MG).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2566

N/A

0DataRank · unranked

5 citations

Dina Randazzo, Vidyalakshmi Chandramohan, Katherine B. Peters, Margaret Johnson, Stevie Threatt +10 more

Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma

Cancers(2021)10.3390/cancers13215367

N/A

0DataRank · unranked

42 citations

Kelly Hotchkiss, Kisha Patel, Daniel Wilkinson, Aditya Mohan, Sarah Cook +2 more

Modified RANO, Immunotherapy RANO, and Standard RANO Response to Convection-Enhanced Delivery of IL4R-Targeted Immunotoxin MDNA55 in Recurrent Glioblastoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0446

N/A

0DataRank · unranked

39 citations

John H. Sampson, Achal S. Achrol, Manish K. Aghi, Krystof Bankiewicz, Chencai Wang +16 more

A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope

npj Vaccines(2021)10.1038/s41541-020-00273-5

N/A

0DataRank · unranked

15 citations

Kendra L. Congdon, Smita K. Nair, Qi-Jing Li, James E. Herndon, Carter M. Suryadevara +6 more

Broad immunophenotyping of the murine brain tumor microenvironment

Journal of Immunological Methods(2021)10.1016/j.jim.2021.113158

N/A

0DataRank · unranked

7 citations

Jessica Waibl Polania, Alexandra Miggelbrink, Molly A. Chakraborty, Peter E. Fecci, John H. Sampson +2 more

Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma

Nature Communications(2022)10.1038/s41467-022-34175-y

N/A

0DataRank · unranked

42 citations

Jessica Waibl Polania, Molly A. Chakraborty, Jonathan Perera, Jeremy Ratiu, Alexandra Miggelbrink +9 more

Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic Radiosurgery

Advances in Radiation Oncology(2022)10.1016/j.adro.2022.101166

N/A

0DataRank · unranked

9 citations

Andrew Fairchild, Justus Adamson, Peter E. Fecci, John H. Sampson, James E. Herndon +7 more

Risk Factors and Neurological Outcomes Associated With Circulatory Shock After Moderate–Severe Traumatic Brain Injury: A TRACK-TBI Study

Neurosurgery(2022)10.1227/neu.0000000000002042

N/A

0DataRank · unranked

9 citations

Jordan Hatfield, Nancy Temkin, Jason Barber, Geoffrey T. Manley, Tetsu Ohnuma +14 more

Reproducibility of outcomes in sequential trials using CMV-targeted dendritic cell vaccination for glioblastoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2005

N/A

0DataRank · unranked

11 citations

Kristen A. Batich, Duane A. Mitchell, James E. Herndon, Gloria Broadwater, Patrick Healy +15 more

A phase 1 trial of D2C7-it in combination with an Fc-engineered anti-CD40 monoclonal antibody (2141-V11) administered intratumorally via convection-enhanced delivery for adult patients with recurrent malignant glioma (MG).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e14015

N/A

0DataRank · unranked

10 citations

Vidyalakshmi Chandramohan, Daniel Landi, Margaret Johnson, Mustafa Khasraw, Katherine B. Peters +12 more

IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastoma

Frontiers in Immunology(2023)10.3389/fimmu.2023.1085547

N/A

0DataRank · unranked

39 citations

Nalini Mehta, Ekaterina Ilich, Steven H. Shen, Daniel Wilkinson, Alexa R. Anderson +5 more

Data from Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas

(2023)10.1158/1078-0432.c.6516909

N/A

0DataRank · unranked

0 citations

David A. Reardon, James E. Herndon, Jennifer Marcello, Jennifer A. Quinn, Jeremy N. Rich +9 more

IL-7–mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models

Journal of Clinical Investigation(2025)10.1172/jci181471

N/A

0DataRank · unranked

5 citations

Kelly Hotchkiss, Sarah Cook, Pamy Noldner, Ying Zhou, Eliese Moelker +12 more